# Alkyl Amines Chemicals share price today (Alkyl Amines Chemicals Ltd, NSE: ALKYLAMINE)

> Alkyl Amines Chemicals share price today: ₹1,589.50 at the NSE close on 4 November 2026, down 10.6% in a year. Alkyl Amines Chemicals (NSE: ALKYLAMINE) is worth ₹8,129 crore, trades at a P/E of 36.1 and has closed between ₹1,278.40 and ₹2,052.70 over the past 52 weeks. > Alkyl Amines Chemicals Ltd's share price has fallen more than its earnings. Earnings per share fell 3.3% in a year while the price moved −10.6%. ALKYLAMINE · Speciality Chemicals · data as of 4 November 2026. Page: https://www.sectoralpha.in/stocks/alkyl-amines-chemicals-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting better, from the last 12 quarters
- Price: ₹1,589.50 (−10.6% in a year)
- P/E: 36.1× (lower than 56% of the last 11 years)
- Revenue (Jun 2026): ₹528 Cr (+30.0% on a year ago)
- Profit (Jun 2026): ₹95.0 Cr (+93.9% on a year ago)
- Operating margin: 25.0% (+6.0 points on a year ago)
- ROCE: 17%, FY26
- ROIC: 16.9%, against a 12.0% cost of capital: +4.9 points

Biggest thing to watch: the price has already been rising for 19 weeks, so timing is the risk more than the business. ## What is the Alkyl Amines Chemicals share price today? Alkyl Amines Chemicals Ltd's share price was ₹1,589.50 at the close on 4 November 2026. It has been rising for 19 weeks. That is 10.7% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹1,278 and ₹2,053, and at that close it sat 40% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 2 weeks running. Over the last 11 years the share price moved +1,133% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 23 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Alkyl Amines Chemicals this quarter? Three changes stood out: profit grew again in the June 2026 quarter, best operating margin in 13 quarters and highest quarterly profit in 21 quarters. 1. Profit grew again in the June 2026 quarter Profit was ₹95 crore, +93.9% on a year earlier (₹49 crore), after 3 quarters of decline. 2. Best operating margin in 13 quarters Operating margin was 25% in the June 2026 quarter, against 19% a year earlier. 3. Highest quarterly profit in 21 quarters Profit of ₹95 crore in the June 2026 quarter is the highest of the last 21 quarters. ## What are Alkyl Amines Chemicals' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Alkyl Amines Chemicals reported revenue of ₹528 crore, up 30.0% from ₹406 crore a year earlier, and a profit of ₹95.0 crore, up 93.9% from ₹49.0 crore. ### Alkyl Amines Chemicals results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹528 crore | ₹406 crore | +30.0% |
| Profit | ₹95.0 crore | ₹49.0 crore | +93.9% |
| Earnings per share | ₹18.50 | ₹9.67 | +91.3% |
| Operating margin | 25.0% | 19.0% | +6.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). The newest call in our records is from 6 May 2026, about January to March 2026; a call about these results is not in our records yet. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Alkyl Amines Chemicals share price history? Alkyl Amines Chemicals closed at ₹1,589.50 on 4 November 2026, down 10.6% from ₹1,777.70 a year earlier (7 November 2025) and down 52.9% over five years. Its highest weekly close since March 2016 was ₹4,386.45 on 30 July 2021. ### Alkyl Amines Chemicals share price: then and now

| When | Close | Change to 4 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 30 Oct 2026 | ₹1,590.10 | 0.0% |
| 1 month ago · 1 Oct 2026 | ₹1,741.25 | −8.7% |
| 6 months ago · 8 May 2026 | ₹1,707.30 | −6.9% |
| 1 year ago · 7 Nov 2025 | ₹1,777.70 | −10.6% |
| 3 years ago · 3 Nov 2023 | ₹2,168.70 | −26.7% |
| 5 years ago · 4 Nov 2021 | ₹3,376.55 | −52.9% |
| 10 years ago · 4 Nov 2016 | ₹129.40 | +1,128.4% |
| Earliest weekly close in our records · 11 Mar 2016 | ₹128.90 | +1,133.1% |
| Highest weekly close since March 2016 · 30 Jul 2021 | ₹4,386.45 | −63.8% |
| Lowest weekly close since March 2016 · 23 Dec 2016 | ₹117.76 | +1,249.8% |
| 52-week high (weekly close) · 21 Aug 2026 | ₹2,052.70 | −22.6% |
| 52-week low (weekly close) · 13 Mar 2026 | ₹1,278.40 | +24.3% |

Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (563 weekly closes from 11 March 2016 to 4 November 2026.)

## What is the latest news on Alkyl Amines Chemicals? 4 Nov 2026: Alkyl Amines Chemicals closed at ₹1,589.50, up 0.0% on the week and down 8.7% on the month. Results for April to June 2026: Revenue up 30.0% and profit up 93.9% on a year earlier. ### Earlier

- 25 Jun 2026: ex-date for a dividend of ₹10 a share, record date 26 Jun 2026. - 6 May 2026: Alkyl Amines Chemicals held its results call for January to March 2026. Management guided: FY27 revenue growth 5-10% at normalized rates; company expects growth alignment with country GDP growth (5-7%)

## What dividend does Alkyl Amines Chemicals pay? Alkyl Amines Chemicals paid ₹10 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.63% at the ₹1,589.50 close on 4 November 2026. The last was a dividend of ₹10 a share, ex-date 25 June 2026. ### Alkyl Amines Chemicals dividends since 1 April 2021

| Ex-date | Dividend per share | Type | Record date |
| --- | --- | --- | --- |
| 25 Jun 2026 | ₹10 | Dividend | 26 Jun 2026 |
| 24 Jun 2025 | ₹10 | Dividend | same day |
| 25 Jun 2024 | ₹10 | Dividend | n/a |
| 4 Jul 2023 | ₹10 | Dividend | n/a |
| 22 Jul 2022 | ₹10 | Dividend | n/a |
| 12 Jul 2021 | ₹6 | Dividend | n/a |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Alkyl Amines Chemicals Ltd paid out 28% of its profit as dividends in FY26, and it paid a dividend in each of its last 18 reported years. (From the NSE corporate-actions record, read 5 November 2026.)

## What did Alkyl Amines Chemicals management say on the latest results call? On the call for January to March 2026, held on 6 May 2026, Alkyl Amines Chemicals' management guided: FY27 revenue growth 5-10% at normalized rates; company expects growth alignment with country GDP growth (5-7%)

> “We expect next year will be a normal year with about 5-10% growth rate”
> Kirat Patel, on the call for January to March 2026

### What management guided

- FY27 capital spending ₹80-90 crore for new product plant completion and engineering projects; excludes new major business capital spending pending market clarity. - Kurkumbh plant mechanical completion end-June FY27 with early Q2 commissioning goal. - One new product launch expected July 2026; dozen R&D projects ongoing but typically 1-2 reach commercialization. - Margin improvement expected vs FY26 baseline but not sustainable at heightened levels; temporary inventory benefit being realized - directional only, no quantified goal. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/890/Conference Call/CC-May26.pdf). (From the call for January to March 2026, 6 May 2026. The April to June 2026 results are out since, so this part may be out of date until we update it.)

## What to watch in Alkyl Amines Chemicals' next results? When Alkyl Amines Chemicals reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Kurkumbh new product plant mechanical completion end-June aiming for early July to September 2026 commissioning - key operational milestone confirming project execution on track despite prior timeline slip. - What to check (from the call)
- Kurkumbh new product plant mechanical completion end-June aiming for early July to September 2026 commissioning - key operational milestone confirming project execution on track despite prior timeline slip. - management claimed temporary benefit from commodity hedging so test pricing resilience with normal sourcing. - Ammonia supply cost trajectory: track movement from current ₹100+/kg back toward pre-war ~₹50/kg; management flagged 3-6 month stabilization timeline from war disruption peak. - New product commercialization launch July 2026: monitor first revenue recognition and ramp trajectory from R&D milestone to commercialization execution. ## Which stock lists is Alkyl Amines Chemicals on? Alkyl Amines Chemicals is not on any of our India lists this week. ## Is Alkyl Amines Chemicals profitable? Alkyl Amines Chemicals Ltd earned ₹95.0 Cr of net profit in the Jun 2026 quarter, +93.9% on the same quarter a year earlier. Full-year FY26 profit was ₹180 Cr. Over 10 years profit has grown 13.7% a year on average. That is 18.0% of the quarter's revenue. The same quarter a year earlier earned ₹49.0 Cr. For the full year, FY26 profit was ₹180 Cr (−3.2% on the year before). Why profit moved: revenue changed +30.0% on a year earlier and the margin moved +6.0 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +19.7% and revenue +4.9%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. FY26-Q4. Revenue 387 cr, PAT 45 cr, OPM 18.3%, this review produced no quarter-level why; see the levers. FY27-Q1. Revenue 528 cr, PAT 95 cr, OPM 25.4%, this review produced no quarter-level why; see the levers. Why-sources: our stock research file (6 September 2026) and the company’s own results for those quarters. ## How much revenue does Alkyl Amines Chemicals make, and is it growing? Alkyl Amines Chemicals Ltd reported ₹528 Cr of revenue in the Jun 2026 quarter, +30.0% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 10 years it has grown 12.2% a year on average. The last full year, FY26, came in at ₹1,536 Cr. The last four reported quarters add to ₹1,658 Cr. FY26 revenue was ₹1,536 Cr, −2.3% on the year before. Recent pace: the last four quarters grew +4.9% on average, against 12.2% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +5.1%, against +7.6% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +21.0%, against +23.7% a year (stabilising). FY26-Q4. Revenue 387 cr, PAT 45 cr, OPM 18.3%, this review produced no quarter-level why; see the levers. FY27-Q1. Revenue 528 cr, PAT 95 cr, OPM 25.4%, this review produced no quarter-level why; see the levers. Why-sources: our stock research file (6 September 2026) and the company’s own results for those quarters. ## How much of every ₹100 of sales does Alkyl Amines Chemicals keep? Alkyl Amines Chemicals Ltd's operating margin was 25.0% in the Jun 2026 quarter, 6.0 percentage points higher than the same quarter a year ago. Across 18 years it has been between 11.0% and 35.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +6.4 percentage points on the year while gross margin changed +3.4 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. FY26-Q4. Revenue 387 cr, PAT 45 cr, OPM 18.3%, this review produced no quarter-level why; see the levers. FY27-Q1. Revenue 528 cr, PAT 95 cr, OPM 25.4%, this review produced no quarter-level why; see the levers. Why-sources: our stock research file (6 September 2026) and the company’s own results for those quarters. ## Is Alkyl Amines Chemicals' profit turning into cash? Over the last 3 years, 151% of Alkyl Amines Chemicals Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹239 Cr of operating cash against ₹180 Cr of profit. After ₹121 Cr of spending on assets, ₹118 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 151% of profit came in as cash: the cash cycle got 17 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets. ## Where does Alkyl Amines Chemicals' cash go? Alkyl Amines Chemicals Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 42 days in FY26, up from 25 days in FY21. It spent ₹276 Cr on assets over the last 3 years. Customers take 55 days to pay, and stock sits for 57 days on average. At FY26 sales of ₹1,536 Cr, each day of that cycle ties up about ₹4.2 Cr, so roughly ₹177 Cr is tied up in the business at any time. FY26: customers took 55 days to pay and stock sat for 57 days, about 1.9 months of sales sitting as stock, for a full cycle of 42 days, longer than FY21's 25. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 57 days. Customers pay about 55 days after that. Suppliers are paid at 70 days. Together that makes the 42-day cycle. Spending on assets: ₹276 Cr over the last 3 years, against ₹202 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹130 Cr (FY26): assets paid for that are not earning yet. In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean. ## What is Alkyl Amines Chemicals' P/E ratio, and how does it compare with its own history? Alkyl Amines Chemicals Ltd's P/E is 36.1×, in the middle of its own history: higher than 44% of past readings. Its usual P/E (the middle reading) is 43.4×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −3.3% while the price moved −10.6%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved −14.0% a year; about −6.9% a year came from earnings growth and about −7.1 percentage points from the multiple (the market paying less); over 10 years the price moved +28.5% a year; about +16.5% a year came from earnings growth and about +12.0 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Alkyl Amines Chemicals business getting better or worse? Alkyl Amines Chemicals Ltd's business is getting better. Profit growth hit its low 8 quarters ago at −26.4% and has recovered to +21.0%, with ROCE steady at 18.7%. This is based on 12 quarters of 4 measures. Why it matters: a lasting rise from a low is what this page is built to show. ## What is the Alkyl Amines Chemicals story, and has it been checked? Alkyl Amines Chemicals Ltd's story is not scored yet against the checks our research set on 6 September 2026. Checks so far: 12 not due yet. Still open: [object Object] · [object Object] · [object Object] · [object Object]

What is not proven yet. [object Object] · [object Object] · [object Object] · [object Object]

The test written in advance. Quarterly operating margin and the inventory-change line, Sep-2026 quarter, OPM falls back to the 18-19% pre-war range while inventory is rebuilt at Rs 100+/kg ammonia, proving the June spike was a one-off. Measured by: Quarterly operating margin and the inventory-change line, Sep-2026 quarter. The test written in advance. Kurkumbh plant commissioning and first new-product revenue, A fourth slip, or another quarter with no disclosure, extending a 6-7 month record of misses. Measured by: Kurkumbh plant commissioning and first new-product revenue by FY27-Q2 (Nov-2026 call). The test written in advance. FY27 volume growth against the redefined 5-10% 'normal', Another mid-year cut to the baseline, a third consecutive downgrade. Measured by: FY27 volume growth against the redefined 5-10% 'normal' FY26 volumes about flat; 'normal' redefined from 10-15% to 5-10% on the May-2026 call by FY27-Q2 and FY27-Q4 calls. Lever 1 · Operating leverage: building. FCF Rs 154/67/102 crore across Mar 2024/25/26 (Rs 323 crore total); spending outflow -277 (Mar 2023) to -137 (Mar 2026); OCF Rs 777 crore vs PAT Rs 515 crore over FY24-26 (150.87%); FY27 capex guided Rs 80-90 crore; borrowings Rs 88 crore to Rs 1 crore. What proves it keeps working: Kanchan Shinde: 'it will be around INR80 crores to INR90 crores' for FY27; Kirat Patel: 'the capex looking at is just completing this project and maintenance capex'. It stops working if OCF fell with the profit trough (275 to 263 to 239) and inventory days fell 85 to 57, a release that reverses on restocking at Rs 100+/kg ammonia, so the cash level is not yet growing, only the capex cycle has turned. Lever 4 · Paying down debt: working now. Borrowings Rs 88 crore (Mar 2023) to Rs 1 crore (Mar 2026); derived debt/equity 0.0007; interest cover 213; interest expense Rs 1 crore in FY26. It stops working if An unanswered Rs 136.7 crore spike in other financial liabilities (vs Rs 1.5 crore a year earlier) was raised on the May-2026 call as the line dropped, an open item the packet cannot check. Lever 5 · Regulatory approval: building. Acetonitrile price from Rs 140-150/kg (FY26 average) to a bit over Rs 200/kg; Chinese imports reduced after they raised their own prices; company share increasing (management statement); benefit began Q4 FY26, two quarters later than first guided. What proves it keeps working: 'In the last quarter... they have reduced their imports because they have raised their prices. So more and more, our market share has been increasing.'

Lever 7 · Consolidation: building. Ethylamines: two players globally (Alkyl and Balaji), market 30,000-35,000 tons, prices stabilized and up to about Rs 200/kg on higher alcohol cost, stable share; methylamines: four players, 80,000-90,000 tons demand vs more than 150,000 tons capacity. What proves it keeps working: 'Ethyl has been only 2 of us, Balaji and us in the market... prices have stabilized. In fact, they have also increased because alcohol has increased and margins have been protected there.'

Sources: our results-season review, 6 September 2026. The story check is re-scored every results season; the record below never changes. ## Did Alkyl Amines Chemicals management deliver what it promised? What Alkyl Amines Chemicals Ltd's management promised, against what actually happened: 3 promises on the record. Read straight from the company’s own earnings calls. A promise that slipped stays on this page after it is met. New Product Commissioning Timeline - Successive Delays Without Substantive Justification · 6 May 2026. The May 2025 call guided mechanical completion of the new product plant by December 2025 or January 2026, while the Nov 2025 call slipped this to February-March 2026 with Q1 FY27 commercialization. The May 2026 call reveals mechanical completion is still pending and now expected only by end of June 2026, pushing commissioning to the start of Q2 FY27 - a cumulative slip of approximately 6-7 months from the original goal - described only as a slight delay with no substantive explanation offered. Ammonia Supply Risk Assessment - Direct Reversal From Prior Dismissal · 6 May 2026. In the Nov 2025 call, management explicitly downplayed the risk of Middle East ammonia supply disruptions, asserting the impact of Iranian sanctions on the supply chain would not be long-lasting and would settle very quickly. The May 2026 call directly contradicts this, disclosing that the company faced grave concerns over availability in March 2026, with prices roughly doubling, and supply chain normalization now expected to take another 3-6 months. Volume Growth Normal Rate - Quietly Redefined Downward · 6 May 2026. Both prior calls explicitly described 10-15% annual volume growth as the company's normal expectation, with the Nov 2025 call treating it as the rate to return to once geopolitical headwinds subsided. The May 2026 call guides to 5-10% volume growth for FY27 and explicitly describes this as a normal year, effectively lowering the stated baseline growth rate by approximately half without explaining whether this represents a temporary adjustment or a structural reset in long-term growth expectations. Every quote above is taken word for word from the company’s own earnings calls. ## How much does Alkyl Amines Chemicals earn on its capital? Alkyl Amines Chemicals Ltd earned a ROCE of 17% in FY26. That is up from a low of 11% in FY09. Its return on capital used (ROIC) is 4.9 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 11.7% net margin and 0.81× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 11.7% net margin × 0.81× asset turnover × 1.24× leverage (assets divided by equity) ≈ 11.8% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 16.9% − 12.0% = +4.9 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. The 16.9% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 12.8%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Alkyl Amines Chemicals have too much debt? Alkyl Amines Chemicals Ltd has total debt of ₹1.0 Cr against shareholder equity of ₹1,533 Cr as of Jun 2026, so its debt is 0.00× its equity, which is very little. Year by year, that ratio went from 0.06 in FY21 to 0.00 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Alkyl Amines Chemicals shareholding pattern? Domestic institutions raised their stake in Alkyl Amines Chemicals Ltd by 1.7 percentage points over 8 quarters, the biggest change among its owners. Domestic institutions now own 3.3% of the company. Foreign institutions moved +0.3 points over the same period, to 3.5%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Domestic institutions: +1.7 points over 8 quarters, to 3.3%; Foreign institutions: +0.3 points over 8 quarters, to 3.5%; Promoters: +0.1 points over 8 quarters, to 72.0%. Why the owners changed: domestic institutions drove it (+1.7 points). They raised their stake step by step. ## How far is Alkyl Amines Chemicals from balance-sheet trouble? For Alkyl Amines Chemicals Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Alkyl Amines Chemicals rank in its industry? 45.5 out of 100, rank 20 of 30 in Speciality Chemicals, with 96% of the evidence available. Alkyl Amines Chemicals Ltd scores 45.5 out of 100 against the 30 companies it is compared with in Speciality Chemicals, ranking 20. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 20.8 + 13.7 + 4.5 + 6.5 = 45.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Alkyl Amines Chemicals compared with? Alkyl Amines Chemicals ranks 20 of 30 Speciality Chemicals companies on the 4-Factor Sector Score, with 45.5 out of 100. 1. [Panama Petrochem Ltd](https://www.sectoralpha.in/stocks/panama-petrochem-ltd) PANAMAPET · turning · Sector-leading setup · 96% evidence 82.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.8/35 · Revenue 45.9% · Profit 100% · Operating margin change 14 points · 88% evidence Capital efficiency 17.6/25 · ROCE 19.2% · Operating margin 22% · 100% evidence Valuation 19.7/20 · P/E 5.7× · PEG 0.18 · 100% evidence Relative strength 13.9/20 · Lead over its industry 16.3% · Lead over NIFTY 500 31.3% · 1 year 68.1% · 100% evidence · 10 of 12 weeks ahead Exact sum: 30.8 + 17.6 + 19.7 + 13.9 = 82 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Yasho Industries Ltd](https://www.sectoralpha.in/stocks/yasho-industries-ltd) YASHO · losing its lead · Most evidence points up · 78% evidence 67.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.0/35 · Revenue 54.2% · Profit 100% · Operating margin change 3 points · 100% evidence Capital efficiency 12.3/25 · ROCE 8.9% · Operating margin 21% · 100% evidence Valuation 12.7/20 · P/E 45× · PEG 1.02 · 65% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 41.1% · 1 year 103.4% · 25% evidence · 11 of 12 weeks ahead Exact sum: 30 + 12.3 + 12.7 + 12.2 = 67.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Vikram Thermo (India) Ltd](https://www.sectoralpha.in/stocks/vikram-thermo-indialtd) breaking out · Evidence leans up · 68% evidence 64.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 16.9% · Profit 41.9% · Operating margin change 8 points · 83% evidence Capital efficiency 21.1/25 · ROCE 36.2% · Operating margin 48% · 95% evidence Valuation 6.6/20 · P/E 25.8× · PEG n/a · 50% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 74.5% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.8 + 21.1 + 6.6 + 12.5 = 64 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. [Sunshield Chemicals Ltd](https://www.sectoralpha.in/stocks/sunshield-chemicals-ltd) SUNSHIEL · quiet · Evidence leans up · 81% evidence 63.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 12.9% · Profit 100% · Operating margin change 5 points · 88% evidence Capital efficiency 18.6/25 · ROCE 19.9% · Operating margin 16% · 100% evidence Valuation 10.8/20 · P/E 24.3× · PEG 2.21 · 100% evidence Relative strength 10.8/20 · Lead over its industry n/a · Lead over NIFTY 500 4.3% · 1 year -4% · 25% evidence · 0 of 5 weeks ahead Exact sum: 23.6 + 18.6 + 10.8 + 10.8 = 63.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Black Rose Industries Ltd](https://www.sectoralpha.in/stocks/black-rose-industries-ltd) BLACKROSE · quiet · Evidence leans up · 81% evidence 60.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 8.6% · Profit 28.6% · Operating margin change 6 points · 88% evidence Capital efficiency 16.3/25 · ROCE 18.7% · Operating margin 16% · 100% evidence Valuation 10.0/20 · P/E 17.1× · PEG 4.96 · 100% evidence Relative strength 10.9/20 · Lead over its industry n/a · Lead over NIFTY 500 4.4% · 1 year n/a · 25% evidence · 7 of 12 weeks ahead Exact sum: 23.6 + 16.3 + 10 + 10.9 = 60.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Tatva Chintan Pharma Chem Ltd](https://www.sectoralpha.in/stocks/tatva-chintan-pharma-chem-ltd) TATVA · losing its lead · Evidence leans up · 93% evidence 59.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.7/35 · Revenue 49.2% · Profit 100% · Operating margin change 1 points · 100% evidence Capital efficiency 8.5/25 · ROCE 7.2% · Operating margin 19% · 100% evidence Valuation 11.3/20 · P/E 60.2× · PEG 1.21 · 65% evidence Relative strength 11.4/20 · Lead over its industry 7.8% · Lead over NIFTY 500 23.3% · 1 year 15.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 28.7 + 8.5 + 11.3 + 11.4 = 59.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Aether Industries Ltd](https://www.sectoralpha.in/stocks/aether-industries-ltd) AETHER · leader · Evidence leans up · 90% evidence 59.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.4/35 · Revenue 30.2% · Profit 28.4% · Operating margin change 1 points · 100% evidence Capital efficiency 12.7/25 · ROCE 11.9% · Operating margin 32% · 100% evidence Valuation 9.7/20 · P/E 85.1× · PEG n/a · 50% evidence Relative strength 14.8/20 · Lead over its industry 22.3% · Lead over NIFTY 500 38.6% · 1 year 114.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 22.4 + 12.7 + 9.7 + 14.8 = 59.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Privi Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/privi-speciality-chemicals-ltd) PRIVISCL · quiet · Evidence leans up · 82% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue 17.5% · Profit 44.5% · Operating margin change -1 points · 95% evidence Capital efficiency 18.5/25 · ROCE 22.3% · Operating margin 26% · 76% evidence Valuation 10.1/20 · P/E 33.7× · PEG n/a · 50% evidence Relative strength 7.1/20 · Lead over its industry -9.7% · Lead over NIFTY 500 4.2% · 1 year 10.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 23.7 + 18.5 + 10.1 + 7.1 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Fineotex Chemical Ltd](https://www.sectoralpha.in/stocks/fineotex-chemical-ltd) FCL · leader · Evidence leans up · 96% evidence 59.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.3/35 · Revenue 91.5% · Profit 41% · Operating margin change -2 points · 88% evidence Capital efficiency 13.6/25 · ROCE 18.3% · Operating margin 16% · 100% evidence Valuation 5.7/20 · P/E 46.1× · PEG 1.92 · 100% evidence Relative strength 19.5/20 · Lead over its industry 34.1% · Lead over NIFTY 500 48.9% · 1 year 62.9% · 100% evidence · 12 of 12 weeks ahead Exact sum: 20.3 + 13.6 + 5.7 + 19.5 = 59.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [DMCC Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/dmcc-speciality-chemicals-ltd) DMCC · quiet · Evidence leans up · 93% evidence 55.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.9/35 · Revenue 72.1% · Profit 34.5% · Operating margin change -6.9 points · 100% evidence Capital efficiency 8.6/25 · ROCE 14.8% · Operating margin 4.2% · 100% evidence Valuation 16.1/20 · P/E 16.9× · PEG 0.44 · 65% evidence Relative strength 7.8/20 · Lead over its industry -12.3% · Lead over NIFTY 500 0.9% · 1 year -15.5% · 100% evidence · 9 of 12 weeks ahead Exact sum: 22.9 + 8.6 + 16.1 + 7.8 = 55.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Aarti Industries Ltd](https://www.sectoralpha.in/stocks/aarti-industries-ltd) AARTIIND · quiet · Evidence leans up · 100% evidence 55.1 out of 100 Growth Capital Valuation Relative
12. [Galaxy Surfactants Ltd](https://www.sectoralpha.in/stocks/galaxy-surfactants-ltd) GALAXYSURF · leader · Evidence leans up · 81% evidence 53.7 out of 100 Growth Capital Valuation Relative
13. [Pidilite Industries Ltd](https://www.sectoralpha.in/stocks/pidilite-industries-ltd) PIDILITIND · quiet · Evidence leans up · 100% evidence 52.8 out of 100 Growth Capital Valuation Relative
14. [DIC India Ltd](https://www.sectoralpha.in/stocks/dic-india-ltd) DICIND · breaking out · Evidence leans up · 81% evidence 52.8 out of 100 Growth Capital Valuation Relative
15. [Neogen Chemicals Ltd](https://www.sectoralpha.in/stocks/neogen-chemicals-ltd) NEOGEN · leader · Evidence leans up · 90% evidence 51.7 out of 100 Growth Capital Valuation Relative
16. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) KRONOX · breaking out · Evidence leans up · 74% evidence 51.6 out of 100 Growth Capital Valuation Relative
17. [Chemcon Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/chemcon-speciality-chemicals-ltd) CHEMCON · breaking out · Evidence leans up · 85% evidence 50.9 out of 100 Growth Capital Valuation Relative
18. [Grauer & Weil (India) Ltd](https://www.sectoralpha.in/stocks/grauer-weil-indialtd) GRAUWEIL · breaking out · Evidence leans down · 96% evidence 46.3 out of 100 Growth Capital Valuation Relative
19. [Paushak Ltd](https://www.sectoralpha.in/stocks/paushak-ltd) PAUSHAKLTD · losing its lead · Evidence leans down · 85% evidence 45.6 out of 100 Growth Capital Valuation Relative
20. Alkyl Amines Chemicals Ltd this page ALKYLAMINE · quiet · Evidence leans down · 96% evidence 45.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.8/35 · Revenue 5.1% · Profit 21% · Operating margin change 6 points · 88% evidence Capital efficiency 13.7/25 · ROCE 16.6% · Operating margin 25% · 100% evidence Valuation 4.5/20 · P/E 36.1× · PEG 5.37 · 100% evidence Relative strength 6.5/20 · Lead over its industry -13.4% · Lead over NIFTY 500 -0.3% · 1 year -14.5% · 100% evidence · 5 of 12 weeks ahead Exact sum: 20.8 + 13.7 + 4.5 + 6.5 = 45.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 21. [Platinum Industries Ltd](https://www.sectoralpha.in/stocks/platinum-industries-ltd) PLATIND · turning · Evidence leans down · 81% evidence 45.5 out of 100 Growth Capital Valuation Relative
22. [Innovassynth Technologies (India) Ltd](https://www.sectoralpha.in/stocks/innovassynth-technologies-indialtd) breaking out · Too little evidence to rank firmly · 53% evidence 44.0 out of 100 Growth Capital Valuation Relative
23. [Anupam Rasayan India Ltd](https://www.sectoralpha.in/stocks/anupam-rasayan-india-ltd) ANURAS · turning · Evidence leans down · 78% evidence 43.7 out of 100 Growth Capital Valuation Relative
24. [Vinati Organics Ltd](https://www.sectoralpha.in/stocks/vinati-organics-ltd) VINATIORGA · quiet · Evidence leans down · 82% evidence 42.4 out of 100 Growth Capital Valuation Relative
25. [Amines & Plasticizers Ltd](https://www.sectoralpha.in/stocks/amines-plasticizers-ltd) AMNPLST · quiet · Evidence leans down · 81% evidence 42.3 out of 100 Growth Capital Valuation Relative
26. [Amal Ltd](https://www.sectoralpha.in/stocks/amal-ltd) AMAL · quiet · Evidence leans down · 68% evidence 41.3 out of 100 Growth Capital Valuation Relative
27. [Transpek Industry Ltd](https://www.sectoralpha.in/stocks/transpek-industry-ltd) TRANSPEK · losing its lead · Evidence leans down · 63% evidence 38.6 out of 100 Growth Capital Valuation Relative
28. [Vishnu Chemicals Ltd](https://www.sectoralpha.in/stocks/vishnu-chemicals-ltd) VISHNU · losing its lead · Evidence leans down · 100% evidence 38.2 out of 100 Growth Capital Valuation Relative
29. [Clean Science & Technology Ltd](https://www.sectoralpha.in/stocks/clean-science-technology-ltd) CLEAN · breaking out · Evidence leans down · 85% evidence 38.1 out of 100 Growth Capital Valuation Relative
30. [Thirumalai Chemicals Ltd](https://www.sectoralpha.in/stocks/thirumalai-chemicals-ltd) TIRUMALCHM · quiet · Most evidence points down · 68% evidence 27.4 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Speciality Chemicals](https://www.sectoralpha.in/sectors/speciality-chemicals), all 30 compared on one page. ## Which companies are close to Alkyl Amines Chemicals in size? Alkyl Amines Chemicals is the 7th largest of 30 Speciality Chemicals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Anupam Rasayan India, Privi Speciality Chemicals and Vinati Organics. Just below it: Clean Science & Technology, Galaxy Surfactants and Neogen Chemicals. ### Speciality Chemicals companies close in size

1. [Anupam Rasayan India Ltd](https://www.sectoralpha.in/stocks/anupam-rasayan-india-ltd) ₹13,019 crore
2. [Privi Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/privi-speciality-chemicals-ltd) ₹12,571 crore
3. [Vinati Organics Ltd](https://www.sectoralpha.in/stocks/vinati-organics-ltd) ₹10,286 crore
4. Alkyl Amines Chemicals Ltd ₹8,132 crore
5. [Clean Science & Technology Ltd](https://www.sectoralpha.in/stocks/clean-science-technology-ltd) ₹7,606 crore
6. [Galaxy Surfactants Ltd](https://www.sectoralpha.in/stocks/galaxy-surfactants-ltd) ₹7,502 crore
7. [Neogen Chemicals Ltd](https://www.sectoralpha.in/stocks/neogen-chemicals-ltd) ₹6,523 crore

[All 30 Speciality Chemicals companies, largest first](https://www.sectoralpha.in/sectors/speciality-chemicals#all-companies)

### Companies close in size in other industries

1. [P N Gadgil Jewellers Ltd](https://www.sectoralpha.in/stocks/p-n-gadgil-jewellers-ltd) ₹8,222 crore · Diamond, Gems & Jewellery
2. [Banco Products (India) Ltd](https://www.sectoralpha.in/stocks/banco-products-indialtd) ₹8,206 crore · Auto Ancillaries - Engine Parts
3. Alkyl Amines Chemicals Ltd ₹8,132 crore
4. [Madhya Bharat Agro Products Ltd](https://www.sectoralpha.in/stocks/madhya-bharat-agro-products-ltd) ₹8,127 crore · Fertilisers
5. [Kennametal India Ltd](https://www.sectoralpha.in/stocks/kennametal-india-ltd) ₹8,105 crore · Castings, Forgings & Fastners

## Quarterly scorecard? Our Alkyl Amines Chemicals Ltd research of 6 September 2026 set 12 checks, and every results season scores each one. No results season has been scored against them yet. A row is permanent: a miss stays on the record after it is fixed. ## What else do people ask about Alkyl Amines Chemicals? ### What is Alkyl Amines Chemicals's share price today? Alkyl Amines Chemicals Ltd's share price is ₹1,589.50, −10.6% over the past year. The whole company is worth ₹8,129 Cr on the market. In the last 52 weeks it traded between ₹1,278 to ₹2,053; today it is 40% of the way up from the low, 10.7% below its 200-day average (as of 4 November 2026). ### What were Alkyl Amines Chemicals's latest quarterly results? Alkyl Amines Chemicals Ltd reported revenue of ₹528 Cr and net profit of ₹95.0 Cr for the Jun 2026 quarter. Revenue rose 30.0% and profit rose 93.9% compared with a year earlier. Earnings per share were ₹18.50. The operating margin was 25.0%, 6.0 percentage points higher than a year earlier (as of 4 November 2026). ### What is Alkyl Amines Chemicals's market cap? Alkyl Amines Chemicals Ltd's market capitalisation is ₹8,129 Cr at a share price of ₹1,589.50. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Alkyl Amines Chemicals performing? Alkyl Amines Chemicals Ltd's share price has been rising for 19 weeks. In its latest quarter, revenue rose 30.0% and profit rose 93.9% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 2 weeks running (as of 4 November 2026). ### Will Alkyl Amines Chemicals's share price go up? This page does not forecast Alkyl Amines Chemicals Ltd's share price. What it shows instead: the share price is ₹1,589.50, and it has been rising for 19 weeks. Its P/E of 36.1× is higher than 44% of its own last 11 years (as of 4 November 2026). ### Who owns Alkyl Amines Chemicals? Promoters own 72.0% of Alkyl Amines Chemicals Ltd, foreign institutions 3.5%, domestic institutions 3.3% and the public 21.3% (latest quarter). The biggest change over the last two years: Domestic institutions raised their stake by 1.7 percentage points over 8 quarters (as of 4 November 2026). ### Where is Alkyl Amines Chemicals in its business cycle? Alkyl Amines Chemicals Ltd's FY26 operating margin was 19.0%, against a 18-year range of 11.0% to 35.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 25.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Alkyl Amines Chemicals story? Biggest thing to watch: the price has already been rising for 19 weeks, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Alkyl Amines Chemicals a stock worth studying right now? What the numbers show: Alkyl Amines Chemicals Ltd's share price has fallen more than its earnings. Earnings per share fell 3.3% in a year while the price moved −10.6%. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). ### Is there a Alkyl Amines Chemicals share price forecast for 2026? What management itself guided: FY27 revenue growth 5-10% at normalized rates; company expects growth alignment with country GDP growth (5-7%)

This is research, not advice. We’re not SEBI-registered.